What are the characteristics of the types of targeted drugs for leukemia in the United States?
First of all, I need to correct you. Medically, it's called leukemia. There were the following types and characteristics of targeted drugs for leukemia in the United States: 1. ** Antibody-drug combinations ** - **Polivy (Polatu Bedotin)**: Target the CD 79b pathway and deliver toxic drugs to the tumor, approved for use in patients with non-Hodgkin's leukemia. - ** Brentment vedotin (Adcetris)**: targets the CD30 pathway and deliver toxic drugs to the tumor. It is approved for use in a sub-group of patients with Hodgkin's or non-Hodgkin's leukemia, including as first-line treatment. - ** Etumomab tiuxetan (Zevalin)**: Target the CD20 pathway and deliver toxic drugs to the tumor, approved for use in patients with non-Hodgkin's leukemia. 2. ** Monoclone Antibodies ** - ** Mogamulizan (Poteligeo)**: A monoclone that targets the CCR4 pathway. It is approved for use in patients with two rare types of non-Hodgkin's leukemia (fungus and Serbkin's disease), which affects the skin. - ** Obinutuzumi (Gazyva)**: Monoclone Antibodies that target the CD20 pathway, approved for use in a sub-set of patients with non-Hodgkin's leukemia, including as first-line treatment. - ** Rituxan (Rituxan)**: Monoclone Antibodies that target the CD20 pathway, approved for use in a sub-set of patients with CD20-positive non-Hodgkin's leukemia (NPC), including as first-line treatment. 3. ** Check Point Inhibition Agents (Immune Regulators)** - ** Nivioluba (Opdivo)**: A checkpoint indicator targeting the PD-L1 pathway, approved for use in a sub-set of patients with classic Hodgkin's leukemia. - ** Pembrolizan (Keytruda)**: A checkpoint indicator of the PD-L1 pathway, approved for use in a sub-set of patients with classic Hodgkin's leukemia. 4. ** Cytokines (Immune Regulators)** - ** Interferon alpha- 2b (IntronA)**: A hormone that targets the IFNAR1/2 pathway and is approved for use in a sub-set of patients with Follicular Malignity. The characteristics of these targeted drugs included: 1. ** High accuracy **: If targeted therapy only targets tumor cells and has no harmful effect on normal cells, the accuracy rate is very high. 2. [High Concentration (Strong Effect): Stronger effect on tumor cells.] Read more exciting novels for free
What are the types of 100 targeted drugs?
According to their chemical structure and mechanism of action, targeted drugs can be divided into the following categories: 1. ** Small Molecules Target Drug **: - ** Tyrosin Kinase Inhibition (TKIs)**: Commonly used in the treatment of lung cancer and other types of cancer. For example, gefitinib, erlotinib, afartinib, osimertinib, etc., which are used for the treatment of lung cancer and can be used when the patient has an egfr-gene mutation; they are also used for other cancer, such as erlotinib in the treatment of intestinal cancer. - ** Multi-Kinase Inhibition **: For example, sorafenib, sunitini, and lenvatini for the treatment of primary liver cancer. 2. ** High-molecular targeted drug **: - ** Monoclone Antibodies (MAb)**: For example, bevacizumi, which is used to treat non-small cell lung cancer and large intestine cancer, targets tumor vasculature, but it often needs to be combined with chemotherapy drugs to achieve better efficacy. There are also trastuzumi, cetuxed, etc., which are used to treat gastric cancer. - ** Immune suppressors (some are targeted, such as PD-L1 and PD-L1)**: It can suppress the binding of the PD-L1 protein on the surface of tumor cells to the PD-L1 protein on the surface of T cells, so that T cells can normally play a role in resisting tumor cells. However, the information provided so far did not clearly mention the specific types of 100 targeted drugs. The above main types could only be summarized from common targeted drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for large B-cell leukemia?
The commonly used targeted drug for large B-cell leukemia was rituxan. It was a large molecular monoclonal-type drug that mainly targeted B-cell leukemia that was positive for CD20. It could be used for first-line treatment of diffuse large B-cell leukemia. There was also odronextamab, which was an anti-CD 3×CD20 bi-specific protein, and mosunetuzan, which also targeted CD3×CD20. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the types of targeted drugs in Henan?
It was known that 17 targeted drugs, including osimertinib, crizotinib, anlotinib, and afartinib, had entered the scope of reimbursement for Henan medical insurance, but it was impossible to determine all types of targeted drugs in Henan based on the available information. However, the common targeted drugs were the first-generation gefitini and erlotini, the second-generation aflatini and dacomitini, and the third-generation osimertinib. Monocentric antibody-type molecular targeted drugs such as trastuzumb (Herceptin), Rituexiu (Mebthera), EMC-C225 (cetoxieb, Erbitux), and Bevacizu (Avastin). Small molecular compounds were commonly used, such as Glivec (ST51, Imatini), Iressa (ZD1839, Gefitini), and OSI774 (Erlotini, Tarcava). <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the similar drugs in the United States?
The same type of medicine of Ujia Le included Retis, Jiaheng, and so on. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs that can be used in the late stage of leukemia?
The targeted drugs available for advanced leukemia were rituxed injection, trastuziab for injection, cetuxed injection, mesaconic acid, imatini tablets, erlotinib tablets, etc. In addition, targeted drugs such as BTL were also an important breakthrough in the treatment of leukemia in recent years, and they had a good treatment effect on some types of leukemia. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the names of the targeted therapy drugs for acute myeloid leukemia?
There are many targeted treatments for acute myeloid leukemia, such as: Veneroclax, midostemine, gittinib, quizartinib, avonib, gemtubizab, idarobin, azacitidine, homoharringtonine, daunorubin, cytarinoside, decitobin, cladribine, mitoxantrone, etc. There were also targeted drugs targeting specific targets such as FLVT3- itd mutation, IDH2 inhibition, etc. In addition, avonib was an allosteric inhibition of IDH1. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There are several types of breast cancer targeted drugs
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There are several types of targeted drugs for mutations in adenomas.
The common driver gene mutations in lung adenomas include mutations in the Epidermal Growth factor receptor gene (EGFR), the anplastic leukemia kinases gene (ALK), the Kirsten rat sarcomas virus gene homolog gene mutation (KRAS), the c-ros proto-oncogene 1 Tyrosin Kinase gene mutation (ROS1), and the RET gene mutation. The corresponding targeted drugs were as follows: 1. ** Mutant of the egFPR gene **: The corresponding targeted drug is egFR-TKi. Mutations in the EGFR gene were more likely to occur in Asians, women, and non-smoking patients with cancerous tumors. Mutations were more common in the exons of the 18th to 21st genes. The total incidence of mutations in the 19th and 21st exons was about 90%. In addition, there were also mutations in the 20 exons of the EGFR gene, but the treatment situation was special. The first-generation and second-generation targeted drugs were not very effective. If the first-line chemotherapy was not effective, the targeted drug bozitini, which was specifically targeted at the 20 exons of the EGFR gene, would be used for treatment. If the drug was resistant, the third-generation targeted drug, amitini, might be used. 2. **ALK Gene Rearrangement **: It usually appears in the form of the fusion gene EML4- ALK. The corresponding targeted drug is not specified, but studies have shown that this gene rearranging is rare. In Asian lung cancer patients, the occurrence rate is 3% - 5%, and it is mostly seen in young people without a history of smoking. 3. **Kras gene mutation **: It was one of the earliest cancer-causing genes that mutated in human cancer, but the article did not mention specific targeted drugs for Kras gene mutation. In China, 8% - 10% of lung cancer patients had Kras gene mutation, and it was related to smoking history. 4. ** ROS1 Gene Rearrangement **: The production of new fusion kinases can lead to malignant tumors. Although the ROS1 gene is only expressed in 1% - 2% of patients with lung cancer, there are still 10,000 - 15,000 patients with lung cancer who have ROS1 gene rearrangements every year. The corresponding types of targeted drugs are not mentioned in the article. 5. **RET gene mutation **: The corresponding targeted drugs mainly include vandetanil, cabotanil, etc. Vandetanil was a multi-target receptor that could inhibit the signaling pathways of the vasothelin growth factor receptor 2, EGFR, and RET. Cabotini was a multi-receptor that was active against RET. It had an anti-tumor effect by blocking the proto-cancerous gene receptor, vasothelin growth factor receptor 2, and RET signaling pathways. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the latest anxiety drugs in the United States?
The latest anxiety medication in the United States was RH94B, a nasal spray that mainly targeted social anxiety disorder. It was a receptor regulator that could activate sensory neurons in the nasal cavity and trigger the neural circuit in the brain to suppress fear and anxiety. There was no need to ingest it all over the body. A nasal spray could quickly achieve a short-lasting anti-anxiety effect. It was currently in the second phase of clinical development. In addition, traditional anti-anxiety drugs such as citalopram, fluvoxamine, paroxobin, fluoxamine, sertraline, etc. could also be used to improve anxiety. The class of decoctions could be used to treat anxiety with digestive symptoms, and busspirone tablets could be used to manage anxiety or relieve anxiety symptoms for a short period of time. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the drugs for drug addiction in the United States?
The drugs used to treat drug addiction in the United States included methadone, bupranorphine, and so on. Studies have shown that drugs such as methadone and bupranorphine can reduce the death rate of addicted patients by half or more. It was a painkiller created during the Second World War to control the symptoms of withdrawal from heroine addiction, thereby reducing antisocial behavior. Buprenorphine was an opiate compound that had both agonistic and antagonizing activities. Its agonistic activity could be used as a replacement therapy to relieve withdrawal symptoms. Its antagonizing activity made its dependence significantly lighter than pure agonists. There were two dosage forms, injection and subtongue, which were convenient to use and effective for a long time. In addition, clondine could also be used to alleviate the symptoms of withdrawal. It could suppress the discharge of the nucleus coeruleus, and the symptoms of withdrawal were related to the discharge of the nucleus coeruleus. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>